SCHEMBL23748613

SCHEMBL23748613

CCCCC(=O)Nc1cccc(C(=O)OC)c1C

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.60
ALDH1A1 P00352 3/20 0.58
KMT2A Q03164 2/20 0.58
ALOX12 P18054 1/20 0.58
SMN1; SMN2 Q16637 2/20 0.54
CETP P11597 1/20 0.52
HDAC3 O15379 1/20 0.51
HDAC4 P56524 1/20 0.51
HDAC1 Q13547 1/20 0.51
HDAC7 Q8WUI4 1/20 0.51
HDAC2 Q92769 1/20 0.51
HDAC10 Q969S8 1/20 0.51
HDAC11 Q96DB2 1/20 0.51
HDAC8 Q9BY41 1/20 0.51
HDAC6 Q9UBN7 1/20 0.51
HDAC9 Q9UKV0 1/20 0.51
HDAC5 Q9UQL6 1/20 0.51
CYP1A2 P05177 1/20 0.51
CYP2C19 P33261 1/20 0.51
POLB P06746 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5928707 0.87 ALDH1A1 (0.74) KDM4EALDH1A1KMT2AALOX12SMN1; SMN2
SCHEMBL4565885 0.86 SELP (0.61) KDM4EALDH1A1SMN1; SMN2CETPHDAC3
SCHEMBL7626848 0.82 ALDH1A1 (0.74) KDM4EALDH1A1KMT2AALOX12SMN1; SMN2
SCHEMBL7630919 0.82 ALDH1A1 (0.74) KDM4EALDH1A1KMT2AALOX12SMN1; SMN2
SCHEMBL11902610 0.82 ALDH1A1 (0.74) KDM4EALDH1A1KMT2AALOX12SMN1; SMN2
SCHEMBL10987960 0.81 SOAT1 (0.59) KDM4EALDH1A1SMN1; SMN2CETPHDAC3
SCHEMBL10981533 0.81 SOAT1 (0.59) KDM4EALDH1A1SMN1; SMN2CETPHDAC3
SCHEMBL10982243 0.81 SOAT1 (0.59) KDM4EALDH1A1SMN1; SMN2CETPHDAC3
SCHEMBL23748672 0.79 KDM4E (0.52) KDM4EALDH1A1KMT2AALOX12SMN1; SMN2
SCHEMBL28643816 0.79 KDM4E (0.62) KDM4EALDH1A1KMT2ASMN1; SMN2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12473249-B2 Aromatic compounds and pharmaceutical uses thereof BASF AS (NO) 2025-11-18 US disclosed
US-20210380521-A1 AROMATIC COMPOUNDS AND PHARMACEUTICAL USES THEREOF BASF AS (NO) 2021-12-09 US disclosed
US-20210380521-A1 AROMATIC COMPOUNDS AND PHARMACEUTICAL USES THEREOF BASF AS (NO) 2021-12-09 US disclosed
EP-3864001-A1 ROMATIC COMPOUNDS AND PHARMACEUTICAL USES THEREOF BASF AS (NO) 2021-08-18 EP disclosed
CN-113166024-A Aromatic compounds and their medical use 巴斯夫股份公司 2021-07-23 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12473249-B2 Aromatic compounds and pharmaceutical uses thereof GLS2, FFAR3, SLC10A1 KDM4E 1204/4885ALDH1A1 530/4885KMT2A 2026/4885
US-20210380521-A1 AROMATIC COMPOUNDS AND PHARMACEUTICAL USES THEREOF GLS2, FFAR3, SLC10A1 KDM4E 1204/4885ALDH1A1 530/4885KMT2A 2026/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.